Public trial registry of the CCC-Munich

Trial AMLSG 09-09

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AMLSG 09-09
World
Full title
:

Phase III study of chemotherapy in combination with ATRA with or without gemtuzumab ozogamicin in patients with acute myeloid leukemia and NPM1 gene mutation Versand mit GO, T: 07345-800610 Info Ulm, Follow Up bis September 2021 im Keller

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2010-02-01
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Katharina Götze 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier